D dimer Testing Market Size, Share, Trends, Growth Outlook

D dimer Testing Market is estimated to increase at a growth rate of 4.9% CAGR over the forecast period from 2024 to 2030.

The D dimer Testing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Analyzers, Reagents & Consumables), By Test Type (Clinical Laboratory Tests, Point-of-Care Tests), By Method (Enzyme-linked Immunosorbent Assay (ELISA), Latex-enhanced Immunoturbidimetric Assays, Fluorescence Immunoassays, Others), By Application (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Others), By End-user (Hospitals, Academic & Research Institutes, Diagnostic Centers, Others).

 

An Introduction to D dimer Testing Market in 2024

The D-dimer testing market in 2024 addresses the demand for laboratory assays and point-of-care tests used in the diagnosis and assessment of thrombotic and fibrinolytic disorders by detecting elevated levels of D-dimer, a fibrin degradation product indicative of ongoing coagulation and fibrinolysis processes. D-dimer tests are utilized in various clinical settings, including emergency departments, intensive care units, and outpatient clinics, to aid in the diagnosis of deep vein thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), and other thromboembolic conditions. Market dynamics are driven by factors such as the increasing incidence of venous thromboembolism (VTE), the aging population, and advancements in assay technologies for sensitive and specific D-dimer detection. Collaboration between diagnostic manufacturers, clinical laboratories, and healthcare providers drives innovation and market growth in D-dimer testing, supporting timely diagnosis and appropriate management of thrombotic disorders.

 

D dimer Testing Market Trend: Increasing Demand for Point-of-Care Testing

The D-dimer Testing market is witnessing a prominent trend towards increasing demand for point-of-care testing (POCT). With advancements in technology enabling the development of portable and rapid diagnostic devices, there is a growing preference for conducting D-dimer tests at the point of care, such as emergency departments, clinics, and physician offices. This trend is driven by the need for quick and accurate assessment of patients suspected of thrombotic disorders, facilitating prompt decision-making and timely initiation of appropriate treatment strategies.

D dimer Testing Market Driver: Growing Incidence of Thrombotic Disorders

A significant driver in the D-dimer Testing market is the growing incidence of thrombotic disorders worldwide. Conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC) continue to pose a significant burden on healthcare systems globally. D-dimer testing plays a crucial role in the diagnosis and management of these conditions by aiding in the exclusion of thrombotic events, guiding further diagnostic workup, and monitoring response to therapy. As the prevalence of thrombotic disorders rises due to factors such as aging populations, sedentary lifestyles, and increasing prevalence of risk factors such as obesity and diabetes, the demand for D-dimer testing is expected to grow steadily.

D dimer Testing Market Opportunity: Expansion into Emerging Markets

An opportunity for growth in the D-dimer Testing market lies in the expansion into emerging markets. As healthcare infrastructure improves and awareness of thrombotic disorders increases in regions such as Asia-Pacific, Latin America, and the Middle East, there is a growing demand for diagnostic tests to aid in the early detection and management of these conditions. By leveraging their expertise in D-dimer testing and partnering with local distributors or healthcare providers, companies can penetrate these markets and address the unmet diagnostic needs, thereby expanding their customer base and driving revenue growth in the long term.

 

D dimer Testing Market Segmentation

By Product

Analyzers

Reagents & Consumables

By Test Type

Clinical Laboratory Tests

Point-of-Care Tests

By Method

Enzyme-linked Immunosorbent Assay (ELISA)

Latex-enhanced Immunoturbidimetric Assays

Fluorescence Immunoassays

Others

By Application

Deep Vein Thrombosis (DVT)

Pulmonary Embolism (PE)

Disseminated Intravascular Coagulation (DIC)

Others

By End-user

Hospitals

Academic & Research Institutes

Diagnostic Centers

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

 

D dimer Testing Market Companies

Abbott

Biomedica Diagnostics

biomérieux SA

Diazyme Laboratories Inc

F. Hoffmann-La Roche Ltd

HORIBA Ltd

Quidel Corp

Sekisui Diagnostics

Siemen Healthineers

Thermo Fisher Scientific Inc

WERFEN

 

Reasons to Buy the D dimer Testing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions

• Gain access to detailed insights on the D dimer Testing Market, encompassing current market size, growth trends, and forecasts till 2030.

• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities

• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends

• Identify lucrative investment avenues and expansion opportunities within the D dimer Testing Market industry, guided by robust, data-backed analysis.

• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics

• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain

• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics

• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

 

1 Introduction to 2024 D dimer Testing Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global D dimer Testing Market Size Outlook, $ Million, 2021 to 2030

3.2 D dimer Testing Market Outlook By Type, $ Million, 2021 to 2030

3.3 D dimer Testing Market Outlook By Product, $ Million, 2021 to 2030

3.4 D dimer Testing Market Outlook By Application, $ Million, 2021 to 2030

3.5 D dimer Testing Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of D dimer Testing Market Industry

4.2 Key Market Trends in D dimer Testing Market Industry

4.3 Potential Opportunities in D dimer Testing Market Industry

4.4 Key Challenges in D dimer Testing Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global D dimer Testing Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global D dimer Testing Market Outlook By Segments

7.1 D dimer Testing Market Outlook by Segments

By Product

Analyzers

Reagents & Consumables

By Test Type

Clinical Laboratory Tests

Point-of-Care Tests

By Method

Enzyme-linked Immunosorbent Assay (ELISA)

Latex-enhanced Immunoturbidimetric Assays

Fluorescence Immunoassays

Others

By Application

Deep Vein Thrombosis (DVT)

Pulmonary Embolism (PE)

Disseminated Intravascular Coagulation (DIC)

Others

By End-user

Hospitals

Academic & Research Institutes

Diagnostic Centers

Others

 

8 North America D dimer Testing Market Analysis And Outlook To 2030

8.1 Introduction to North America D dimer Testing Markets in 2024

8.2 North America D dimer Testing Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America D dimer Testing Market size Outlook by Segments, 2021-2030

By Product

Analyzers

Reagents & Consumables

By Test Type

Clinical Laboratory Tests

Point-of-Care Tests

By Method

Enzyme-linked Immunosorbent Assay (ELISA)

Latex-enhanced Immunoturbidimetric Assays

Fluorescence Immunoassays

Others

By Application

Deep Vein Thrombosis (DVT)

Pulmonary Embolism (PE)

Disseminated Intravascular Coagulation (DIC)

Others

By End-user

Hospitals

Academic & Research Institutes

Diagnostic Centers

Others

 

9 Europe D dimer Testing Market Analysis And Outlook To 2030

9.1 Introduction to Europe D dimer Testing Markets in 2024

9.2 Europe D dimer Testing Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe D dimer Testing Market Size Outlook By Segments, 2021-2030

By Product

Analyzers

Reagents & Consumables

By Test Type

Clinical Laboratory Tests

Point-of-Care Tests

By Method

Enzyme-linked Immunosorbent Assay (ELISA)

Latex-enhanced Immunoturbidimetric Assays

Fluorescence Immunoassays

Others

By Application

Deep Vein Thrombosis (DVT)

Pulmonary Embolism (PE)

Disseminated Intravascular Coagulation (DIC)

Others

By End-user

Hospitals

Academic & Research Institutes

Diagnostic Centers

Others

 

10 Asia Pacific D dimer Testing Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific D dimer Testing Markets in 2024

10.2 Asia Pacific D dimer Testing Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific D dimer Testing Market size Outlook by Segments, 2021-2030

By Product

Analyzers

Reagents & Consumables

By Test Type

Clinical Laboratory Tests

Point-of-Care Tests

By Method

Enzyme-linked Immunosorbent Assay (ELISA)

Latex-enhanced Immunoturbidimetric Assays

Fluorescence Immunoassays

Others

By Application

Deep Vein Thrombosis (DVT)

Pulmonary Embolism (PE)

Disseminated Intravascular Coagulation (DIC)

Others

By End-user

Hospitals

Academic & Research Institutes

Diagnostic Centers

Others

 

11 South America D dimer Testing Market Analysis And Outlook To 2030

11.1 Introduction to South America D dimer Testing Markets in 2024

11.2 South America D dimer Testing Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America D dimer Testing Market size Outlook by Segments, 2021-2030

By Product

Analyzers

Reagents & Consumables

By Test Type

Clinical Laboratory Tests

Point-of-Care Tests

By Method

Enzyme-linked Immunosorbent Assay (ELISA)

Latex-enhanced Immunoturbidimetric Assays

Fluorescence Immunoassays

Others

By Application

Deep Vein Thrombosis (DVT)

Pulmonary Embolism (PE)

Disseminated Intravascular Coagulation (DIC)

Others

By End-user

Hospitals

Academic & Research Institutes

Diagnostic Centers

Others

 

12 Middle East And Africa D dimer Testing Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa D dimer Testing Markets in 2024

12.2 Middle East and Africa D dimer Testing Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa D dimer Testing Market size Outlook by Segments, 2021-2030

By Product

Analyzers

Reagents & Consumables

By Test Type

Clinical Laboratory Tests

Point-of-Care Tests

By Method

Enzyme-linked Immunosorbent Assay (ELISA)

Latex-enhanced Immunoturbidimetric Assays

Fluorescence Immunoassays

Others

By Application

Deep Vein Thrombosis (DVT)

Pulmonary Embolism (PE)

Disseminated Intravascular Coagulation (DIC)

Others

By End-user

Hospitals

Academic & Research Institutes

Diagnostic Centers

Others

 

13 Company Profiles

13.1  Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

Abbott

Biomedica Diagnostics

biomérieux SA

Diazyme Laboratories Inc

F. Hoffmann-La Roche Ltd

HORIBA Ltd

Quidel Corp

Sekisui Diagnostics

Siemen Healthineers

Thermo Fisher Scientific Inc

WERFEN

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

D dimer Testing Market Segmentation

By Product

Analyzers

Reagents & Consumables

By Test Type

Clinical Laboratory Tests

Point-of-Care Tests

By Method

Enzyme-linked Immunosorbent Assay (ELISA)

Latex-enhanced Immunoturbidimetric Assays

Fluorescence Immunoassays

Others

By Application

Deep Vein Thrombosis (DVT)

Pulmonary Embolism (PE)

Disseminated Intravascular Coagulation (DIC)

Others

By End-user

Hospitals

Academic & Research Institutes

Diagnostic Centers

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)